Home Xiangyu Medical's Transcranial Magnetic Stimulator Selected for MIIT's 2025 High-End Medical Equipment Promotion Program

Xiangyu Medical's Transcranial Magnetic Stimulator Selected for MIIT's 2025 High-End Medical Equipment Promotion Program

Dec 04, 2025 21:05 CST Updated 21:05
Sunnyou

Intelligent Rehabilitation Equipment R&D and Manufacturer

(Source:Sunnyou Medical

Source: Sunnyou Medical

On November 25, the Ministry of Industry and Information Technology publicized2025 High-End Medical Equipment Promotion and Application ProjectThe selection results show that only 57 projects were selected nationwide.

Sunnyou Medical and Beijing Tiantan Hospital, Capital Medical University-led ApplicationTranscranial Magnetic Stimulator Promotion and Application ProjectSuccessfully listed!This important breakthrough not only demonstrates the fruitful cooperation between Sunnyou Medical and top medical institutions but also marks the recognition at the national level of the company's technical strength and product competitiveness in the field of high-end medical equipment.

The "Project for the Promotion and Application of High-End Medical Equipment" is a joint initiative carried out by the Ministry of Industry and Information Technology, the National Health Commission, and the National Medical Products Administration. It aims to select a group of projects that are at the forefront in China in terms of technological innovation and clinical application, targeting key products and typical scenarios in high-end medical equipment. These projects play a strong leading role in promoting medical-engineering collaborative innovation, pilot testing, clinical research, iterative upgrades, and the promotion and application of advanced technologies, new products, and new scenarios on a large scale.

In the future, Sunnyou will further increase its R&D investment, accelerate the iterative upgrading of product technology, and contribute to the development of China's high-end medical equipment industry. Advanced medical equipment will benefit a wider patient population and contribute to the implementation of the Healthy China strategy.